Kailiang Zhao
-
- Cancer-related Molecular Pathways 5
- Cancer Immunotherapy and Biomarkers 5
-
- Hepatocellular Carcinoma Treatment and Prognosis 6
-
- Ubiquitin and proteasome pathways 6
- RNA modifications and cancer 6
-
- Immune cells in cancer 4
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 5
-
- Liver Disease Diagnosis and Treatment 4
- Co-authors
- Yide MeiDecai WangChenfeng WangWeixing WangLilong ZhangMian WuYang YangZhendong Qiu
- Cited by
- Cancer ResearchOncologyHepatology
- Partner nations
- ChinaUnited StatesVietnam
In The Last Decade
Kailiang Zhao
33 papers receiving 352 citations
Peers
Comparison fields: 5 of 76
- Cancer Research 73
- Oncology 117
- Hepatology 32
- Molecular Biology 182
- Immunology 54
Countries citing papers authored by Kailiang Zhao
This map shows the geographic impact of Kailiang Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kailiang Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kailiang Zhao more than expected).
Fields of papers citing papers by Kailiang Zhao
This network shows the impact of papers produced by Kailiang Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kailiang Zhao. The network helps show where Kailiang Zhao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kailiang Zhao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 8 | |
| 7 | 2024 | 3 | |
| 8 | 2024 | 0 | |
| 9 | 2023 | 8 | |
| 10 | 2023 | 9 | |
| 11 | 2023 | 8 | |
| 12 | 2023 | 37 | |
| 13 | 2023 | 6 | |
| 14 | 2023 | 5 | |
| 15 | 2023 | 2 | |
| 16 | 2023 | 20 | |
| 17 | 2023 | 12 | |
| 18 | 2023 | 5 | |
| 19 | 2022 | 6 | |
| 20 | 2021 | 10 |
About Kailiang Zhao
Kailiang Zhao is a scholar working on Hepatology, Oncology and Cancer Research, having authored 38 papers that have together received 354 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers), RNA modifications and cancer (6 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Cancer-related Molecular Pathways (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Immune cells in cancer (4 papers). The work is most often cited by research in Cancer Research (73 citations), Oncology (117 citations) and Hepatology (32 citations). Kailiang Zhao has collaborated with scholars based in China, United States and Vietnam. Frequent co-authors include Yide Mei, Decai Wang, Chenfeng Wang, Weixing Wang, Lilong Zhang, Mian Wu, Yang Yang, Zhendong Qiu, Guang Zhang and Yang Yang. Their work appears in journals such as International Immunopharmacology, BMC Cancer, EMBO Reports, Frontiers in Oncology and International Journal of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.